Breast Cancer Immunodiagnosis and Immunotherapy

Abstract

Session I.- The Potential of Synthetic Tumor - Associated Glycoconjugates S-TAGs) for Generating Monoclonal Antibodies for Breast Cancer Imaging and for Speific Immunotherapy.- Extracellular Keratins: An Update.- Preclinical Evaluation of MoAbs Mc5 and BrEl.- The Use of Human Monoclonal Antibodies to Identify and Isolate Breast Tumor Associated Antigens.- Clinical and Molecular Investigations of the DF3 Breast Cancer - Associated Antigen.- An Assay For Cryptic Tumor Antigens in Sera of Women With Breast Cancer.- Session II.- Biosynthesis of the Cell Surface Sialomucin From Ascites 13762 Rat Mammary Adenocarcinoma Cels: Intracellular Maturation.- Epithelial Mucin Antibodies and Their Epitopes: Core Protein Epitopes of a Polymorphic Epithelial Mucin (PEM).- Cell Heterogeneity and Complexity of Breast Epithelial Surface Antigens Expression and MoAb Therapy.- The Oncogenic Potential of Membrane Receptor Proteins Encoded by Members of the Human erbB Proto-Oncogene Family.- Session III.- Estrogen and Progesterone Receptor Analysis and Action in Breast Cancer.- Monoclonal Antibodies Against Steroid Receptors and Steroid-Induced Proteins.- Ten Year Survival Patterns in Primary Breast Cancers Compared to Hormone Receptor Antigen Detection by Monoclonal Antibodies.- Significance of Steroid Receptor Immunoassay in Breast Cancer.- H23 Monoclonal Antibodies Recognize a Breast Tumor Associated Antigen: Clinical and Molecular Studies.- Complementation of Monoclonal Antibodies DF3 and B72.3 in Reactivity to Breast Cancer.- Differential Expression of DF3 Antigen Between Papillary Carci - nomas and Benign Papillary Lesions of the Breast.- Session IV.- Potentiation of Anti-Tumor Efficacy Resulting From the Combined Administration of Interferon and ofan Anti-Breast Epithelial Monoclonal Antibody in the Treatment of Breast Cancer Xenografts.- Immunolymphscintigraphy with BCD-F9 Monoclonal Antibody and its F(ab)'2 Fragments for the Preoperative Staging of Breast Cancers.- Reaction of Antibodies to Human Milk Fat Globule (HMFG) With Synthetic Peptides.- Individually Specified Drug Immunoconjugates in Cancer Treatment.- A Phase I Study of the Anti-Breast Cancer Immunotoxin 2609 MAB-rRA Given by Continuous Infusion.- In Vivo Studies of Radiolabeled Monoclonal Antibodies MC5 and KC4 Human Breast Cancer.- Contributors.